Countering Beijing’s Weaponization of Fentanyl Act or the CBW Fentanyl Act This bill establishes escalating sanctions to be applied to a foreign country when certain individuals associated with its government cause harm to another country through actions related to a program to produce, develop, or distribute chemical or biological weapons or specified molecules related to fentanyl production. Specifically, if the President determines that an official, employee, or agent of a foreign governmental entity (including a foreign government or an entity receiving significant material support from a foreign government) acts in a manner that the individual knew, or should have known, would harm another country through actions related to such a program, then the President must impose initial sanctions. Initial sanctions include prohibiting the procurement of goods or services from persons operating in that country's chemical or biological sectors. If the foreign governmental entity does not take corrective actions, the President must impose additional sanctions, which may include terminating certain foreign assistance to the country. If corrective actions are still not taken, the President must prohibit transactions that (1) are subject to U.S. jurisdiction; (2) involve a financial interest of the sanctioned country; and (3) are in foreign commerce or are financial institution transfers or payments. Within five years of enactment, the President may temporarily waive sanctions for vital national security interests. The President must terminate sanctions when certain conditions are met, including that the sanctionable conduct has been addressed.
Read twice and referred to the Committee on Foreign Relations.
Bill introduced
Lobbying filed by FDD ACTION
Lobbying filed by FDD ACTION
Read twice and referred to the Committee on Foreign Relations.
| Registrant | Client | Amount | Filed | Period | Issues |
|---|---|---|---|---|---|
| FDD ACTION | FDD ACTION | $170.0K | Jul 21, 2025 | 2025Q2 | BANDEFFOR |
| FDD ACTION | FDD ACTION | $150.0K | Apr 21, 2025 | 2025Q1 | HOMINTBAN |
The lobbying table lists Senate LDA quarterly reports (LD-2) that cite this bill by number and cover a quarter of the 119th Congress. An LD-2 names a bill as “H.R. 1234” with no Congress, so a report on another Congress, which can only concern a different bill with the same number, is left out, even when it was filed after this Congress began. The amount is what the registrant reported for the whole filing, across every issue on it, not spending on this bill. Official actions and the bill summary come from Congress.gov, and votes from the roll-call record. This page no longer pairs the bill with members' stock trades: matching lobbying clients to traded companies by name, and trades to a bill by date, is not something the records establish.